Subacute sensory neuronopathy in small cell cancer of the lung. Immunocytochemical study of 2 cases
Kida, E.; Barcikowska, M.; Joachimowicz-Jaskowiak, E.; Michalska, T.; Siekierzynska, A.; Walasik, A.; Roszkowski, K.; Figura-Chojak, E.
Clinical Neuropathology 13(2): 64-70
1994
ISSN/ISBN: 0722-5091 PMID: 8205728 Document Number: 434343
Two cases of subacute sensory neuronopathy (SSN) associated with small cell lung cancer are reported. In both cases motor disability, attributed to motor neuropathy and neuronopathy, respectively, accompanied SSN. Immunohistochemical studies performed provide further data suggesting the involvement of humoral antibodies and the participation of protease inhibitors in the pathogenesis of SSN.
Document emailed within 1 workday
Related Documents
Okishio, K.; Kudoh, S.; Katsumoto, E.; Ohtsuka, T.; Shoji, S.; Fujii, T.; Kanazawa, H.; Hirata, K.; Kurihara, N.; Yoshikawa, J. 1996: Small-cell lung cancer and subacute sensory neuropathy in a patient positive for the anti-Hu antigen Nihon Kyobu Shikkan Gakkai Zasshi 34(7): 816-821Neill, H.B.; Miller, A.A.; Clamon, G.H.; Perry, M.C.; Crawford, J.; Green, M.R. 1997: A phase Ii study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer Seminars in Oncology 24(4 Suppl 12: S12
Chaari, A.; Ben Nasr, S.; Labidi, S.; Afrit, M.; Boussen, H. 2015: Metastatic non-small cell lung cancer: a Tunisian retrospective study about 100 cases La Tunisie Medicale 93(5): 294-296
Levin, W.J.; Press, M.F.; Gaynor, R.B.; Sukhatme, V.P.; Boone, T.C.; Reissmann, P.T.; Figlin, R.A.; Holmes, E.C.; Souza, L.M.; Slamon, D.J. 1995: Expression patterns of immediate early transcription factors in human non-small cell lung cancer. the Lung Cancer Study Group Oncogene 11(7): 1261-1269
Perng, R.P.; Chien, K.Y.; Chen, K.Y. 1989: Combined modality treatment for non-small cell lung cancer. Lung Cancer Study Group Zhonghua Yi Xue Za Zhi 43(4): 217-222
Eskenasy, A. 1986: The microcellular (oat cell, small cell anaplastic) carcinoma of the lung. A histopathological study of 620 diagnosed cases Morphologie et Embryologie 32(4): 257-269
Dong, Q.-g.; Han, B.-h.; Huang, J.-s.; Yang, L.-m.; Huang, J.; Zhao, C.-y.; Lu, L.-q. 2006: Analysis of EGFR mutations in 176 cases of non-small cell lung cancer Zhonghua Zhong Liu Za Zhi 28(9): 686-690
Munzuroglu, F.; Erturan, S.; Oz, B.; Dincbas, F.O.; Demir, G. 2009: Non small cell lung cancer within the small cell lung cancer radiotherapy field after 11 years Journal of Buon: Official Journal of the Balkan Union of Oncology 14(2): 313-316
Hirose, T.; Hosaka, T.; Nakashima, M.; Sugiyama, T.; Ishida, H.; Yamaoka, T.; Okuda, K.; Adachi, M. 2008: Two cases with recurrent non-small cell lung cancer successfully treated with cisplatin and S-1 Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(2): 327-330
Kosmidis, P.A.; Samantas, E.; Fountzilas, G.; Pavlidis, N.; Apostolopoulou, F.; Skarlos, D. 1994: Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase IIi study. Hellenic Cooperative Oncology Group for Lung Cancer Trials Seminars in Oncology 21(3 Suppl 6: 23-30
Bando, T.; Fujimura, M.; Kasahara, K.; Matsuda, T. 1998: Significance of Na+, K(+)-ATPase on intracellular accumulation of cis-diamminedichloroplatinum(II) in human non-small-cell but not in small-cell lung cancer cell lines Anticancer Research 18(2a): 1085-1089
Gu, A.-q.; Wang, H.-m.; Shi, C.-l.; Xiong, L.-w.; Gao, Z.-q.; Han, B.-h. 2010: Clinical observation of gefitinib for the treatment of 125 cases with advanced non-small cell lung cancer Zhonghua Zhong Liu Za Zhi 32(1): 71-74
Battikh, M.H.; Ben Sayah, M.M.; Joobeur, S.; Rouetbi, N.; Ben Salem, K.; Daami, M.; Maatallah, A.; Raham, W.; Farhat, C.; El Kamel, A. 2004: Survival and prognostic factors of non small cell lung cancer: analytic review of 211 cases La Tunisie Medicale 82(9): 843-848
Suzuki, H.; Sasada, S.; Matsuda, Y.; Otani, Y.; Morishita, N.; Kobayashi, M.; Okamoto, N.; Hirashima, T.; Matsui, K.; Kawase, I. 2008: Two cases of severe myelosuppression from amrubicin in previously-treated small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(3): 491-493
Benaiges, D.; Zanui, M.; Chillaron, J.José.; Arriola, E.; Garrigos, L.; Pedro-Botet, J. 2012: Two cases of pituitary metastases as initial presentation form of small cell lung cancer Investigacion Clinica 53(4): 402-407
Luikart, S.D.; Propert, K.J.; Modeas, C.R.; Green, M.R.; Perry, M.C. 1987: High-dose etoposide therapy for extensive small cell lung cancer: a Cancer and Leukemia Group B Study Cancer Treatment Reports 71(5): 533-534
Jankowicz, E.; Drozdowski, W. 1999: Sensory neuronopathy Neurologia i Neurochirurgia Polska 33(3): 621-632
Makarewicz, R.; Kuźmińska, A. 1996: Use of intraluminal brachytherapy for treatment of patients with non-small cell lung cancer in cases of local failure after teleradiotherapy Pneumonologia i Alergologia Polska 64(7-8): 444-449
Zhang, X.; Sun, Y.; Kong, W. 1998: Navelbine plus cisplatin combination therapy in the treatment of advanced non-small cell lung cancer: a report of 42 cases Zhonghua Zhong Liu Za Zhi 20(1): 60-62
Korobowicz, E.; Zdunek, M. 2000: Immunohistochemical study of p53 in non-small cell lung cancer before and after preoperative chemotherapy Polish Journal of Pathology: Official Journal of the Polish Society of Pathologists 51(2): 71-76